公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2019 | Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C – authors’ reply | CHEN-HUA LIU ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 0 | 0 | |
2019 | Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction? | CHEN-HUA LIU ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 1 | 1 | |
2023 | Editorial: Noninvasive tests for metabolic dysfunction-associated steatotic liver disease: A refinement of the Nash-FibroTest for type 2 diabetes mellitus | CHEN-HUA LIU | Alimentary pharmacology & therapeutics | |||
2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
2011 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C | CHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 19 | |
2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2007 | Enterolith ileus in a patient with jejunal diverticulosis: Sonographic findings | CHEN-HUA LIU ; KAI-WEN HUANG ; Mo Y.-H.; PEI-MING YANG | Journal of Clinical Ultrasound | 5 | 6 | |
2008 | Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis | CHEN-HUA LIU ; SHIH-JER HSU ; Liang C.-C.; FENG-CHIAO TSAI ; JOU-WEI LIN ; CHUN-JEN LIU ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN | Radiology | 27 | 24 | |
2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 43 | |
2021 | Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy | CHEN-HUA LIU ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Liu W.-C.; WANG-HUEI SHENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Journal of Viral Hepatitis | 6 | 6 | |
2020 | Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) | Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. | The American journal of gastroenterology | 20 | 17 | |
2009 | Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 33 | 30 | |
2022 | Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals | Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators | Viruses | 1 | 1 | |
2021 | Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan | Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Yu M.-L. | Liver International | 25 | 23 | |
2015 | Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients | Wang C.-C.; CHEN-HUA LIU ; Lin C.-L.; Wang P.-C.; TAI-CHUNG TSENG ; Lin H.H.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 27 | 27 | |
2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
2011 | Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Lin Y.-L.; CHUN-JEN LIU ; BOR-LUEN CHIANG ; JIA-HORNG KAO | Journal of Medical Virology | 10 | 7 |